Reports

Roblox Reports First Quarter 2022 Financial Results

Roblox Reports First Quarter 2022 Financial Results

Revenue up 39% over prior year up to $537.1 million Strong year over year growth in Daily Active Users and Hours Engaged, up 28% and 22%, respectively SAN MATEO, Calif., May 10, 2022–(BUSINESS WIRE)–Roblox Corporation (NYSE: RBLX), a global platform bringing millions of people together through shared experiences, released its first quarter 2022 financial results …

Roblox Reports First Quarter 2022 Financial Results Read More »

SoFi Technologies, Inc. Reports First Quarter 2022 Results

SoFi Technologies, Inc. Reports First Quarter 2022 Results

SAN FRANCISCO–(BUSINESS WIRE)–SoFi Technologies, Inc. (NASDAQ: SOFI), a member-centric, one-stop shop for digital financial services that helps members borrow, save, spend, invest and protect their money, reported financial results today for its first quarter ended March 31, 2022. “We delivered another quarter of great results, with record adjusted net revenue up 49% year-over-year, a seventh …

SoFi Technologies, Inc. Reports First Quarter 2022 Results Read More »

The above map shows the 25 states that have confirmed or suspected hepatitis cases according to the CDC. Hawaii today became the 25th state to reveal it is probing a suspected case of the illness (yellow), with Puerto Rico also having reported at least one case

Hawaii reports mysterious hepatitis in child under 10 years old

Hawaii has become the 25th state to begin probing a case of mysterious hepatitis in a child less than ten years old — after five deaths and more than 100 cases were reported across America. The state’s Department of Health said the child was hospitalized with abdominal pain and fever on Maui, its second largest island, …

Hawaii reports mysterious hepatitis in child under 10 years old Read More »

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights

Achieved revenue of $704 million and net income of $203 million highlighting the first profitable quarter as a commercial stage company Reiterating full year 2022 total revenue guidance of between $4 and $5 billion Continued label expansion including primary, booster and adolescent authorizations and new shipments of Nuvaxovid™ into European Union, Canada, South Korea, Australia …

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights Read More »